90 related articles for article (PubMed ID: 20661710)
1. Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product.
Alsarra IA; Alanazi FK; Ahmed SM; Bosela AA; Alhamed SS; Mowafy HA; Neau SH
Arch Pharm Res; 2010 Jul; 33(7):1009-17. PubMed ID: 20661710
[TBL] [Abstract][Full Text] [Related]
2. Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.
Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
AAPS PharmSciTech; 2012 Sep; 13(3):863-74. PubMed ID: 22669594
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model.
Alomrani AH; Shazly GA; Amara AA; Badran MM
Colloids Surf B Biointerfaces; 2014 Sep; 121():74-81. PubMed ID: 24937135
[TBL] [Abstract][Full Text] [Related]
4. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
[TBL] [Abstract][Full Text] [Related]
5. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes.
Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B
Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
[TBL] [Abstract][Full Text] [Related]
7. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
Kumar N; Shishu ; Bansal G; Kumar S; Jana AK
Drug Dev Ind Pharm; 2013 Feb; 39(2):342-51. PubMed ID: 22553909
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity.
Patel NR; Damann K; Leonardi C; Sabliov CM
Nanomedicine (Lond); 2010 Sep; 5(7):1037-50. PubMed ID: 20874019
[TBL] [Abstract][Full Text] [Related]
10. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.
Maincent JP; Najvar LK; Kirkpatrick WR; Huang S; Patterson TF; Wiederhold NP; Peters JI; Williams RO
Drug Dev Ind Pharm; 2017 Feb; 43(2):264-274. PubMed ID: 27645428
[TBL] [Abstract][Full Text] [Related]
11. Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities.
Uchida T; Somada A; Kagoshima Y; Konosu T; Oida S
Bioorg Med Chem Lett; 2008 Dec; 18(24):6538-41. PubMed ID: 18974000
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation.
Tang J; Wei H; Liu H; Ji H; Dong D; Zhu D; Wu L
Drug Deliv; 2010 May; 17(4):223-30. PubMed ID: 20210560
[TBL] [Abstract][Full Text] [Related]
13. Analytical study of photodegradation of inclusion complexes of nimodipine with alpha-, gamma-cyclodextrin, methyl-beta-cyclodextrin, and hydroxypropyl-beta-Cyclodextrin.
Mielcarek J
Drug Dev Ind Pharm; 1998 Feb; 24(2):197-200. PubMed ID: 15605453
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution.
Yang W; Chow KT; Lang B; Wiederhold NP; Johnston KP; Williams RO
Eur J Pharm Sci; 2010 Mar; 39(5):336-47. PubMed ID: 20093186
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
16. Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).
Tell LA; Craigmill AL; Clemons KV; Sun Y; Laizure SC; Clifford A; Ina JH; Nugent-Deal JP; Woods L; Stevens DA
J Vet Pharmacol Ther; 2005 Jun; 28(3):267-74. PubMed ID: 15953200
[TBL] [Abstract][Full Text] [Related]
17. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin modulates the cytotoxic effects of chlorhexidine on microrganisms and cells in vitro.
Teixeira KI; Denadai AM; Sinisterra RD; Cortés ME
Drug Deliv; 2015 May; 22(3):444-53. PubMed ID: 24491181
[TBL] [Abstract][Full Text] [Related]
19. Encapsulating insoluble antifungal drugs into oleic acid-modified silica mesocomposites with enhanced fungicidal activity.
Zhu P; Zhou L; Song Y; Cai L; Ji M; Wang J; Ruan G; Chen J
J Mater Chem B; 2020 Jun; 8(22):4899-4907. PubMed ID: 32314756
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.
Athanassiou G; Michaleas S; Lada-Chitiroglou E; Tsitsa T; Antoniadou-Vyza E
J Pharm Pharmacol; 2003 Mar; 55(3):291-300. PubMed ID: 12724033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
